EGFR and lung cancer: By employing the mathematical model, the authors showed that phosphorylation and ubiquitination of EGFR are uncoupled in lung cancer cells harbouring EGFR mutations without overexpression [72], suggesting that the impaired EGFR ubiquitination is enhancing EGFR signalling and therefore the tumourigenic characteristics.